Hands On With Campfire’s New Holographic Computing Enterprise Headset And Platform

0x0
I’ve been aware of San Diego-based XR company Campfire since CES last year, where I swore to secrecy in order to gain access to its first AR demos. Since then, Campfire has quickly matured into a complete solution for professional 3D design and collaboration —one that explicitly seeks take advantage of existing platforms to advance and improve AR and VR. Campfire has already raised $8M in seed funding and its platform is on pace for commercial availability before the end of this year. However, while Campfire could easily be mistaken for just another AR or VR headset, it is much more than that. Let’s take a closer look. The headset If Campfire’s headset looks familiar, that’s because a lot of the headset’s IP comes from the defunct Meta View AR headset which shut down in 2019 and sold to what would become Campfire. While Meta View’s...

Archer Materials Ltd and Max Kelsen strengthen collaboration to develop quantum computing algorithms

1200z630 1616032921 2021 03 18 13 02 01 1cfadfcb44be68be225794f9dd295a01
The algorithms are key to the operation of Archer's 12CQ quantum computing chip and the two companies have outlined a detailed development roadmap for adapting IBM’s Qiskit Pulse toolkit to be used with 12CQ prototype chips. () () (FRA:38A) has strengthened its collaboration with Brisbane-based AI firm Max Kelsen to develop quantum computing algorithms relevant to the operation of the 12CQ quantum computing chip. The collaboration, which was announced in December last year, is a key step in the commercialisation of the 12CQ chip and aims to validate chip end-uses and high-value practical applications. Archer's CEO Dr Mohammad Choucair along with senior management recently travelled to Brisbane to meet the CEO and R&D teams of Max Kelsen to enhance the collaboration and learn more about the Max Kelsen business to explore strategic...

Roche taps into quantum computing software for Alzheimer’s disease research

GettyImages 1193095471
Alzheimer’s disease has proven to be stubbornly difficult to unravel, but Roche aims to tap into a new tool that promises to accelerate the process: the quantum computer.  Through a multi-year partnership with the U.K.’s Cambridge Quantum Computing, the Swiss drugmaker’s task force plans to explore the nascent technology’s potential for designing and delivering new therapeutic compounds.  The partnership follows a similar endeavor launched earlier this year between Google and Boehringer Ingelheim, which plans to staff its own quantum laboratory as part of the Big Pharma’s digital transformation. Google has also been developing its own quantum hardware, in the Sycamore processor, which it says has outperformed so-called “classical” supercomputers. While typical machines use the binary system of 1s and 0s to solve...